series-a
Stage
2
Investors
About
Mozart Therapeutics is a clinical-stage biopharmaceutical company focused on developing CD8 Treg modulators to treat autoimmune diseases by restoring immune balance and preventing tissue damage caused by autoimmune responses.
Explore Mozart Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.